1. Home
  2. NUVL vs BETA Comparison

NUVL vs BETA Comparison

Compare NUVL & BETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$98.09

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

BETA

Beta Technologies Inc.

N/A

Current Price

$16.77

Market Cap

7.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NUVL
BETA
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
7.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
BETA
Price
$98.09
$16.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
8
Target Price
$135.33
$37.88
AVG Volume (30 Days)
436.1K
1.1M
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,064.25
$1,051.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$55.54
$15.64
52 Week High
$113.02
$36.43

Technical Indicators

Market Signals
Indicator
NUVL
BETA
Relative Strength Index (RSI) 42.01 38.32
Support Level $73.22 $15.64
Resistance Level $107.13 $31.55
Average True Range (ATR) 3.82 1.50
MACD -0.35 0.03
Stochastic Oscillator 19.08 3.74

Price Performance

Historical Comparison
NUVL
BETA

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About BETA Beta Technologies Inc.

BETA Technologies Inc is an aerospace company manufacturing electric flight. It designs, manufactures and sells high-performance electric aircraft, advanced electric propulsion systems, charging systems and components. The company has one operating and reportable segment - Development and Manufacturing Electric Aircrafts. Its products include: Aircraft, Charge, Motor, Battery, and Flight Controls.

Share on Social Networks: